ENTITY
Novotech Holdings

Novotech Holdings (NVT HK)

13
Analysis
Health CareChina
Largest biotech specialist contract research organization (CRO) in Asia
more
23 Nov 2021 23:16

Asymchem Laboratories H Share Listing: On-Demand Science

Asymchem is pre-marketing an H Share listing to raise $1.5 billion, according to press reports. The forward indicators suggest that the near-term...

Logo
298 Views
Share
01 Oct 2021 11:33

Novotech Health IPO: Forecasts, Peer Comparison and Thoughts on Valuation

Novotech Health is an Asia-Pacific biotech-focused CRO and in this insight, we provide our forecasts for the company’s financials and what could be...

Share
bearishBroncus
15 Sep 2021 16:55

Broncus IPO Valuation: Overly Ambitious

Our reverse DCF suggests that the revenues need to grow at a CAGR of 86.3% in order to justify the implied IPO valuation of HK$7.68bn which seems...

Share
09 Sep 2021 10:12

Novotech Pre-IPO: PHIP and Valuation Update

We look at the latest update of the Novotech's financials and operation. With new information, we provide a more detailed forecast and valuation.

Logo
239 Views
Share
08 Sep 2021 18:48

Novotech Health IPO: Valuation First-Look

Novotech is pre-marketing an HKEx IPO to raise $0.5-1.0 billion. In this note, we present our forecasts and take the first look at Novotech's...

Logo
285 Views
Share
x